(Q53846551)

20 May 2018

title

Peripheral neuropathy does not invariably coexist with autonomic neuropathy in diabetes mellitus. (English)

1 reference

20 May 2018

1 reference

N Tentolouris

1

1 reference

20 May 2018

S Pagoni

series ordinal

2

1 reference

20 May 2018

A Tzonou

series ordinal

3

1 reference

20 May 2018

N Katsilambros

series ordinal

4

1 reference

20 May 2018

publication date

1 February 2001

1 reference

20 May 2018

European Journal of Internal Medicine

published in

1 reference

20 May 2018

volume

12

1 reference

20 May 2018

issue

1

1 reference

20 May 2018

page(s)

20-27

1 reference

20 May 2018

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Mortality in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Mortality in diabetic patients with cardiovascular autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Peripheral motor nerve function in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Divergent development of autonomic and peripheral somatic neuropathies in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

The value of cardiovascular autonomic function tests: 10 years experience in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Corrected QT interval in relation to the severity of diabetic autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Cough test to assess cardiovascular autonomic reflexes in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Diagnosis and management of diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Painful neuropathy and foot ulceration in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Vibration Perception Threshold: Influence of Age, Height, Sex, and Smoking, and Calculation of Accurate Centile Values

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Dissociated sensory loss in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Autoimmunity in diabetic autonomic neuropathy: does the immune system get on your nerves?

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

An investigation of antibodies to nerve growth factor in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Pathology of Autonomic Neuropathy in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

The role of endogenous nerve growth factor in human diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

Growth factors and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2800%2900128-X

7 January 2021

10.1016/S0953-6205(00)00128-X

Identifiers

DOI

1 reference

20 May 2018

1 reference

20 May 2018